Health & Medicine
Novartis's Drug for Lung Cancer Gets FDA Nod
Novertis drug Zykadia is now approved by the U.S. Food and Drug Administration for use in patients with a certain type of lung cancer.
Latest Research Articles
Increasing Fiber Intake Helps Heart Attack Survivors Live Longer
Newborn Size Data Reassessed in New Study, Gives Doctors More Accurate Data
Being Called Fat Increases Obesity Risk in Girls
Loss of Y chromosome Linked to High Cancer Risk, Early Death in Men
Silencing Genes Linked with Fear Could Help People Cope with Phobia, Researchers Say
Sanofi's Experimental Dengue Vaccine Shows Promising Results
Soy- Dairy Combo Post Exercise Helps Build Muscle Mass, Researchers Say
Breath Compounds Could be Used to Detect Larynx Cancer, Researchers Say
Pet Bearded Dragons Carry Rare Form of Salmonella
Unhappy Marriage Linked to Depression
Smoke-Free Policies May Significantly Improve Heart Health
Vitamin D No Help in Fall Risk Among Elderly




